Single Immunochemical Fecal Occult Blood Test for Detection of Colorectal Neoplasia
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Purpose: This study was designed to investigate the validity of a single immunochemical fecal occult blood test (FOBT) for detection of colorectal neoplasia. Materials and Methods: A total of 3,794 average-risk screenees and 304 colorectal cancer patients admitted to the National Cancer Center, Korea, between May 2001 and November 2002, were studied prospectively. All screenees and admitted patients underwent FOBT and total colonoscopic examinations. Stools were self-collected, and examined using an immunochemical fecal occult blood test (OC-hemodia , Eiken Chemical Co. Tokyo, Japan) and an OC-sensor analyzer (Eiken Chemical Co. Tokyo, Japan). Results: Of the 3,794 asymptomatic screenees, the colonoscopy identified colorectal adenomas and cancers in 613 (16.2%) and 12 (0.3%) subjects, respectively. The sensitivities of a single immunochemical FOBT for detec- ting colorectal cancers and adenomas in screenees were 25.0 and 2.4%, respectively. The false positive rate of FOBT for colorectal cancer in screenees was 1.19%. For the total 316 colorectal cancer cases (including 12 cases from screenees), the FOBT sensitivities according to the T-stage were 38.5, 75.0%, 78.9 and 79.2% for T1, 2, 3 and 4 cancers, respectively. The sensitivities according to the Dukes stages A, B and C were 63.4, 79.3 and 78.6%, respectively. Conclusion: The sensitivities of a single immunochemical FOBT for detecting colorectal cancers and adenomas in screenees were 25.0 and 2.4%, respectively. The sensitivities of FOBT were about 80% for Dukes B or C colorectal cancers and 63.4% for Dukes A.
Abstract
Purpose: This study was designed to investigate the validity of a single immunochemical fecal occult blood test (FOBT) for detection of colorectal neoplasia. Materials and Methods: A total of 3,794 average-risk screenees and 304 colorectal cancer patients admitted to the National Cancer Center, Korea, between May 2001 and November 2002, were studied prospectively. All screenees and admitted patients underwent FOBT and total colonoscopic examinations. Stools were self-collected, and examined using an immunochemical fecal occult blood test (OC-hemodia , Eiken Chemical Co. Tokyo, Japan) and an OC-sensor analyzer (Eiken Chemical Co. Tokyo, Japan). Results: Of the 3,794 asymptomatic screenees, the colonoscopy identified colorectal adenomas and cancers in 613 (16.2%) and 12 (0.3%) subjects, respectively. The sensitivities of a single immunochemical FOBT for detec- ting colorectal cancers and adenomas in screenees were 25.0 and 2.4%, respectively. The false positive rate of FOBT for colorectal cancer in screenees was 1.19%. For the total 316 colorectal cancer cases (including 12 cases from screenees), the FOBT sensitivities according to the T-stage were 38.5, 75.0%, 78.9 and 79.2% for T1, 2, 3 and 4 cancers, respectively. The sensitivities according to the Dukes stages A, B and C were 63.4, 79.3 and 78.6%, respectively. Conclusion: The sensitivities of a single immunochemical FOBT for detecting colorectal cancers and adenomas in screenees were 25.0 and 2.4%, respectively. The sensitivities of FOBT were about 80% for Dukes B or C colorectal cancers and 63.4% for Dukes A.
참고문헌 (24)
- "Overview of the epidemiology of colorectal cancer", 40, pp.483~93 (1997)
- "Cancer incidence in Korea", 34, pp.405~8 (2002)
- "Experience of 1 446 rectal cancer patients in Korea andanalysis of prognostic factors", 14, pp.101~6 (1999)
- "Efficacy in standard clinical practice of colonoscopic polypectomyin reducing colorectal cancer incidence", 48, pp.812~5 (2001)
- "The effect of fecal occult-blood screeningon incidence of colorectal cancer", 343, pp.1603~7 (2000)
- "Reducing mortality from colorectal cancerby screening for fecal occult blood", pp.1365~71 (1993)
- "Randomised study of screening for colorectal cancer withfecal occult blood test", 348, pp.1467~71 (1996)
- "Randomised controlled trial of fecaloccult-blood screening for colorectal cancer", 348, pp.1472~7 (1996)
- "A comparisonof fecal occult-blood tests for colorectal cancer screening", 334, pp.155~9 (1996)
- "Sensitivity and specificity of several immunochemicaltests for colorectal cancer", 45, pp.1579~82 (1998)
- "The classification of cancer of the rectum", 35, pp.323~ (1932)
- "American Cancer Society guidelinesfor the early detection of cancer: update of early detection guidelinesfor prostate, colorectal, and endometrial cancers", pp.38~75 (2001), update 2001- testing for early lung cancer detection
- "SonnenbergA. Colorectal cancer prevention 2000: screening recommendationsof the American College of Gastroenterology.", pp.868~77 (2000)
- "Which coloncancer screening test? A comparison of costs, effectiveness,and compliance.", 111, pp.593~601 (2001)
- "Comparative screening with asensitive guaiac and specific immunochemical occult bloodtest in an endoscopic study", 89, pp.46~52 (2000)
- "One-time screening for colorectalcancer with combined fecal occult-blood testing and examinationof the distal colon", 345, pp.555~60 (2001)
- "Colonoscopic evaluation of immunochemical fecal occultblood test for detection of colorectal neoplasia", 46, pp.228~31 (1999)
- "Evaluation of the sensitivity of an immunochemical fecaloccult blood test for colorectal neoplasia", 90, pp.1076~9 (1995)
- "Factors of colorectal cancer and adenoma affecting immunologicalfecal occult blood test", 37, pp.428~35 (2001)
- "Quantitative fecal recovery of ingestedhemoglobin-heme in blood:Comparisons by HemoQuant assaywith ingested meat and fish", 89, pp.19~26 (1985)
- "Evaluation of the optimumcut-off point in immunochemical occult blood testing inscreening for colorectal cancer", 37, pp.398~401 (2001)
- "Prevention of colorectal cancer by colonoscopicpolypectomy", 329, pp.1977~81 (1993)
- "Multiple primary colorectal cancer", 17, pp.94~102 (1985)
- "Using colonoscopy to screen forcolorectal cancer", 89, pp.1765~6 (1994)